Interview with Greg Alden. He is the CEO of Diagnostic Biochips – a company providing high fidelity research tools to neuroscientists for electrophysiology and more. He spent the early years of his career optimizing data communications to solve big problems in the domains of broadband and mobile communications. He now brings this set of useful expertise to the neurotech world. We have a conversation talking about everything from the future of neurotechnology innovation, Greg’s journey into the field (in part sparked by his diagnosis with a neurological condition), management principles for a technical organization, and more! Recorded January 16, 2024. Hosts: Robert Murcko and Yuqing Wang.
Key Moments
0:00 Intro
1:54 Parkinson’s Diagnosis
3:06 Applying Tech to Neuro Problems
4:08 Brain as a Distributed Computing Networking Function
5:03 Interest in Neuroscience
7:14 Involvement with Diagnostic Biochips
9:46 Commercialization of Diagnostic Biochips’ Products
11:30 Transitioning from Telecom to Neurotech
14:03 Market Landscape and Diagnostic Biochips’ Place In It
17:21 From Idea Stage through Go-to-Market
21:20 Advice for Academics Looking to Translate Their Technology
23:59 Technical vs. Business Priorities
26:29 Diagnostic Biochips’ Products and Offerings
29:28 Cloud-Based Analysis Platform
35:24 Diagnostic Biochips Contributions to the Field of Neuroscience
40:03 Advice for Getting Involved with Neurotech
42:23 The Future of Neurotechnology
46:42 Conclusion and Contact Information
Links
Free Neurotech Newsletter:
https://neurotechnologynews.beehiiv.com/subscribe
Diagnostic Biochips: https://diagnosticbiochips.com/
Greg’s LinkedIn: https://www.linkedin.com/in/gregjalden/
